Matches in Nanopublications for { ?s ?p "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP395435.RA3xWGk1mW6I-CiQob7sIQgOrlDf1BLhHxnsHQMv4PtwM130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395435.RA3xWGk1mW6I-CiQob7sIQgOrlDf1BLhHxnsHQMv4PtwM130_provenance.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.
- NP225205.RAKYv_RDqd1k9-lejvsbiKXRvMD8YdurYICkzeX_WkPQ8130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225205.RAKYv_RDqd1k9-lejvsbiKXRvMD8YdurYICkzeX_WkPQ8130_provenance.
- NP746740.RAye1s5apTIFP0gpEV24d9HYchGoNHy_5Ko6QQACLnkHE130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746740.RAye1s5apTIFP0gpEV24d9HYchGoNHy_5Ko6QQACLnkHE130_provenance.
- NP773040.RAx5LU_bs8uw9KRUtTSPNhD8rIo31E6B28bznyhqerXtQ130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773040.RAx5LU_bs8uw9KRUtTSPNhD8rIo31E6B28bznyhqerXtQ130_provenance.
- NP819711.RAER4B1f1AYFJ7OHhzJCUUa5zaw8y2QchqrLl7n_RFLMQ130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819711.RAER4B1f1AYFJ7OHhzJCUUa5zaw8y2QchqrLl7n_RFLMQ130_provenance.